
Vobicil 0.3mg Tablet
Marketer
Albia Biocare
Salt Composition
Voglibose (0.3mg)
Overview Vobicil 0.3mg Tablet
Diabetol 0.3mg tablets are prescribed for managing type 2 diabetes. This medication aids in regulating post-prandial hyperglycemia (high blood sugar after meals). It's indicated when dietary modifications and other similar medications prove insufficient in controlling elevated blood glucose. Diabetol 0.3mg tablets should be administered immediately before meals. Dosage and frequency are determined by your physician to optimize blood sugar control. Abrupt cessation should be avoided without medical consultation; discontinuation may lead to dangerously high blood sugar, potentially causing severe complications like renal impairment and vision loss. This medication forms part of a comprehensive treatment plan including a balanced diet, regular physical activity, and weight management as directed by your doctor. Regular blood glucose monitoring is essential during treatment. Common side effects include flatulence, abdominal discomfort, appetite suppression, constipation, and diarrhea. Report persistent or bothersome side effects to your doctor. While Diabetol 0.3mg tablets alone don't cause hypoglycemia, concurrent use with other anti-diabetic agents (particularly insulin or sulfonylureas) may increase this risk. Treat hypoglycemic episodes with plain glucose; sucrose is ineffective in this context. Inform your physician of any kidney or liver conditions before commencing treatment. Avoid use if you have bowel inflammation or ulceration (e.g., Crohn's disease or ulcerative colitis). Pregnant or lactating individuals should seek medical advice prior to use. Disclose all current medications to ensure safe usage. Limit alcohol consumption as it may elevate hypoglycemia risk.
Uses of Vobicil 0.3mg Tablet
Managing type 2 diabetes
Major Benefits of Vobicil 0.3mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 0.3mg Vobicil tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
Common Side effects of Vobicil 0.3mg Tablet:
- Skin rash
- Flatulence
- Abdominal pain
- Diarrhea
How to use Vobicil 0.3mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Administer Vobicil 0.3mg Tablet on an empty stomach.
How Vobicil 0.3mg Tablet works:
Glucozym 0.3mg tablets are used to manage diabetes. Their mechanism of action involves suppressing enzymes within the gut that digest complex carbohydrates, thus mitigating postprandial hyperglycemia.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Vobicil 0.3mg Tablet is inadvisable.
PregnancySAFE IF PRESCRIBED
The use of Vobicil 0.3mg tablets during pregnancy is generally regarded as safe. Preclinical trials in animals revealed minimal or no harmful effects on fetal development; nevertheless, clinical data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Use of 0.3mg Vobicil tablets while breastfeeding is likely safe. Available human data indicates minimal infant risk from this medication.
DrivingSAFE
Driving ability is typically unaffected by Vobicil 0.3mg tablets.
KidneyCAUTION
Patients with severe kidney impairment should exercise caution when using Vobicil 0.3mg tablets. Dosage modification may be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use 0.3mg Vobicil tablets cautiously, potentially requiring dosage modification. Physician consultation is advised.
What if you forget to take Vobicil 0.3mg Tablet :
Omit any missed dose of Vobicil 0.3mg Tablet and resume your usual medication regimen. Avoid taking a double dose.
Facts to Know About Vobicil 0.3mg Tablet
| Label | Value |
|---|---|
| Type of Compound | Compound derived from valiolamine |
| Addictive | None. |
| Treatment Category | Medication for diabetes |
| Mechanism of Action | Agents that inhibit alpha-glucosidase |
